FDA Adverse Event Other Summary report: N

MEDIUM SLIP ON BRIEF

MDR report key: 3999023 · Received August 5, 2014

Report

Report Number
1033903-2014-00001
Event Type
Other
Date Received
August 5, 2014
Report Date
August 4, 2014
Manufacturer
COVIDIEN
Product Code
EYQ
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
NOT APPLICABLE

Narratives

Additional Manufacturer Narrative · 1

AN INVESTIGATION IS CURRENTLY UNDERWAY, UPON COMPLETION THE RESULTS WILL BE FORWARDED.

Description of Event or Problem · 1

IT WAS REPORTED TO COVIDIEN ON (B)(6) 2014 THAT A CUSTOMER HAD AN ISSUE WITH A BRIEF. THE CUSTOMER REPORTS RECEIVING A RASH FROM THE BRIEFS. THE CUSTOMER ALSO STATED SHE WENT TO A WALK-IN CLINIC AND THE DOCTOR GAVE HER AN ANTIBIOTIC, BUT THE CUSTOMER WAS UNABLE TO NAME THE MEDICATION.

Description of Event or Problem · 1

TWO SAMPLES WERE RECEIVED FOR FURTHER REVIEW HOWEVER NOTHING WAS OBSERVED THAT WOULD INDICATE A CAUSE FOR SKIN IRRITATION. SINCE A MANUFACTURING LOT NUMBER WAS NOT SUPPLIED BY THE CUSTOMER, IT WAS NOT POSSIBLE TO REVIEW THE DEVICE HISTORY RECORD (DHR) FOR THE PARTICULAR MANUFACTURE DAY. DUE TO THE NATURE OF THIS TYPE OF PRODUCT, IT IS MORE THAN LIKELY THAT ANY SKIN IRRITATION IS RELATED TO SKIN SENSITIVITY, AND IT IS WORTH NOTING THAT PATIENT SENSITIVITIES MAY HAVE BEEN A CONTRIBUTING FACTOR. OUR RAW MATERIALS ARE TESTED FOR BIOCOMPATIBILITY PRIOR TO USE AND THERE HAVE BEEN NO DESIGN CHANGES TO THIS PRODUCT WITHIN THE PAST YEAR THAT WOULD CONTRIBUTE TO ANY INCREASED PROBABILITY FOR SKIN IRRITATION ON PATIENTS. AT THIS TIME, A CORRECTIVE ACTION WILL NOT BE IMPLEMENTED. OUR CURRENT CONTROLS ARE SEMI-HOURLY OPERATOR INSPECTIONS OF THE FINISHED PRODUCT FOR MEETING SPECIFICATIONS AND QA MONITORING TWICE PER SHIFT. THIS COMPLAINT HAS BEEN COMMUNICATED TO ALL AFFECTED PERSONNEL. THIS COMPLAINT WILL ALSO BE USED FOR TRENDING AND TRACKING PURPOSES.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
456049 MEDIUM SLIP ON BRIEF BRIEF EYQ COVIDIEN 1605 UNK

Patients

Seq Age Sex Outcome Treatment
1 UNK Other